World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
70
Citations
20591
World Ranking
1914
National Ranking
810

Overview

Douglas T. Dieterich is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily spans the field of Medicine, with an emphasis on subfields including Epidemiology, Hepatology, Infectious Diseases, Surgery, and Cancer Research.

Their scholarly output includes extensive work on several main topics, such as Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, HIV/AIDS drug development and treatment, Pancreatitis Pathology and Treatment, and HIV/AIDS Research and Interventions.

The scientist's frequent collaborators include Paul Y. Kwo, Hie-Won Hann, Ho Bae, Tatyana Kushner, and Mark Sulkowski.

Douglas T. Dieterich has published extensively in peer-reviewed venues. The most frequent publication venues are:

  • Journal of Hepatology
  • Open Forum Infectious Diseases
  • Gastroenterology
  • Clinical Gastroenterology and Hepatology
  • JHEP Reports

Selected recent papers include:

  • Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis, 2020, Gastroenterology
  • Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma, 2020, Oncogene
  • Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer, 2021, Gut
  • Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update, 2021, Clinical Gastroenterology and Hepatology
  • Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection, 2022, Journal of Hepatology

Best Publications

  • Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

    Francesca J. Torriani;Maribel Rodriguez-Torres;Jürgen K. Rockstroh;Eduardo Lissen

  • Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study

    Naga Chalasani;Herbert L. Bonkovsky;Robert Fontana;William Lee

  • A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update

    Emmet B. Keeffe;Douglas T. Dieterich;Steven Huy B. Han;Ira M. Jacobson

  • Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

    Susanna Naggie;Curtis Cooper;Michael Saag;Kimberly Workowski

  • A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An Update

    Emmet B. Keeffe;Douglas T. Dieterich;Steven–Huy B. Han;Ira M. Jacobson

  • Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

    David L. Wyles;Peter J. Ruane;Mark S. Sulkowski;Douglas Dieterich

  • A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.

    Emmet B. Keeffe;Douglas T. Dieterich;Steve Huy B. Han;Ira M. Jacobson

  • A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin

    Mark G. Swain;Ming–Yang Lai;Mitchell L. Shiffman;W. Graham E. Cooksley

  • Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

    Emmet B. Keeffe;Stefan Zeuzem;Raymond S. Koff;Douglas T. Dieterich

  • Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

    Nezam H. Afdhal;Douglas T. Dieterich;Paul J. Pockros;Eugene R. Schiff

  • Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

    Vincent Soriano;Mark Sulkowski;Colm Bergin;Angelos Hatzakis

  • Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

    Eric Lawitz;Jay P Lalezari;Tarek Hassanein;Kris V Kowdley

  • Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies

    Paul A. Volberding;Alexandra M. Levine;Douglas Dieterich;Donna Mildvan

  • Increasing burden of liver disease in patients with HIV infection

    Deepak Joshi;John O'Grady;Doug Dieterich;Brian Gazzard

  • Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.

    Mark S. Sulkowski;Susanna Naggie;Jacob Lalezari;Walford Jeffrey Fessel

  • Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.

    Norbert Bräu;Norbert Bräu;Rena K. Fox;Peiying Xiao;Kristen Marks

  • American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.

    Siddharth Singh;Andrew J. Muir;Douglas T. Dieterich;Yngve T. Falck-Ytter

  • Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.

    Douglas T Dieterich;Ronald Wasserman;Norbert Bräu;Norbert Bräu;Tarek I Hassanein

  • Care of patients with hepatitis C and HIV co-infection.

    Vincent Soriano;Massimo Puoti;Mark Sulkowski;Stefan Mauss

  • Drug-Induced Liver Injury Associated with the Use of Nonnucleoside Reverse-Transcriptase Inhibitors

    Douglas T. Dieterich;Patrick A. Robinson;James Love;Jerry O. Stern

  • Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.

    Mark S Sulkowski;Kenneth E Sherman;Douglas T Dieterich;Mohammad Bsharat

Frequent Co-Authors

Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine
Zobair M. Younossi
Zobair M. Younossi Inova Health System
Bruce R. Bacon
Bruce R. Bacon Saint Louis University
Kris V. Kowdley
Kris V. Kowdley Washington State University
Nezam H. Afdhal
Nezam H. Afdhal Beth Israel Deaconess Medical Center
Jürgen K. Rockstroh
Jürgen K. Rockstroh University Hospital Bonn
Ira M. Jacobson
Ira M. Jacobson New York University
Scott L. Friedman
Scott L. Friedman Icahn School of Medicine at Mount Sinai
Vincent Soriano
Vincent Soriano Universidad Internacional De La Rioja
Peter Ferenci
Peter Ferenci Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various allied health and science careers. For students seeking flexible learning options, exploring what medical degrees can I get online can help identify suitable programs that blend biology and healthcare, accessible from anywhere.

Public health is another complementary field, and many students consider pursuing a Master of Public Health (MPH) after microbiology. To find manageable entry points, it’s useful to know which online mph programs are easiest to get into, making it an attractive pathway for career advancement without stringent admission barriers.

Additionally, some graduates explore roles supporting children’s health and well-being, such as becoming a child life specialist. Understanding the certified child life specialist salary and certification requirements helps aspirants evaluate this rewarding profession.

Online degrees also increase accessibility for individuals with diverse backgrounds. For example, if you have a criminal record, knowing about the degrees for felons can guide you toward programs designed for fresh starts and career rebuilding.

Best Scientists Citing Douglas T. Dieterich

Trending Scientists

Recently Published Articles